2nd Edition of International Summit on Hematology and Blood Disorders
June 05-07, 2025
Hematology and Pharma Industry
Hematology is the branch of medicine that deals with blood and bone marrow abnormalities, such as anaemia, coagulation problems, and malignancies like leukaemia. Pharmacometrics and quantitative systems pharmacology (QSP) are increasingly being employed in model-informed drug discovery and development (MID3) of new haematological medications, as well as clinical tools to improve the efficacy of existing therapies. More than a century ago, the linkages between quantitative pharmacology and haematology were identified. Since it is often predicted to be enhanced over the years and years, the entire market for haematological medications is at a high point. From 2015 to 2021, the haematology sedate and expressive market is expected to grow at a rate of 7.5 percent, according to the overall market master.
Jie Xu
The University of Texas MD Anderson Cancer Center, United States
Ravishankar Rao Baikady
The Royal Marsden NHS Foundation Trust, United Kingdom
Peter J Van Der Spek
Erasmus University Medical Center, Netherlands
Aida I Richardson
Ann & Robert H. Lurie Children's Hospital of Chicago, United States
Maryam Asif
University of Washington, United States
Raykina Elena
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Russian Federation
Santosh Kumar Mondal
Department of Pathology and Laboratory Medicine AIIMS, IndiaSubmit your abstract Today
Title : Single cell multi-omics in PBMC’s
Peter J Van Der Spek, Erasmus University Medical Center, Netherlands
Title : Myeloid neoplasms and molecular genetic alterations (Germline vs Somatic) that characterize specific entities in pediatric patients
Aida I Richardson, Ann & Robert H. Lurie Children's Hospital of Chicago, United States
Title : Overview of 2021 guidelines on the diagnosis of Von Willebrand Disease (VWD)
Maryam Asif, University of Washington, United States
Title : Clonal evolution in children with inherited bone marrow failure syndromes
Raykina Elena, Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Russian Federation
Title : Defining the clinical contribution of platelet-derived FXIII-A to regulation of fibrinolysis
Fahad S Alshehri, King Faisal Medical City for Southern Region, Saudi Arabia
Title : Multiple alloantibodies: The strategy for identifying antibodies and transfusion management
Ahmed Alharbi, King Abdulaziz Medical City, Saudi Arabia